You searched for viral vector - Page 6 of 53

News and Trends 10 Jan 2020

Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B

…procedure involves delivering genetic instructions to the ciliary muscle in the eye via an electric current or ‘electrotransfection’, which is less invasive than gene therapies using a viral vector. The…

January 10, 2020 - 3 minutesmins - By Jonathan Smith

amryt skin gene therapy epidermolysis bullosa

News and Trends 8 Jan 2019

Topical Gene Therapy Shows Early Promise for Inherited Skin Disease

…in human skin cells and tissue with the disease-causing mutation. Unlike many similar therapies, Amryt’s gene therapy uses no viral vectors for delivering the gene. Instead, the DNA is carried…

January 8, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Oct 2021

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

…in Europe are based on either adenoviral vectors, including vaccines from AstraZeneca and Johnson & Johnson, or newer messenger mRNA (mRNA) technology including vaccines from BioNTech/Pfizer and Moderna. Their exclusive…

October 26, 2021 - 5 minutesmins - By Victor Kotsev

News and Trends 7 Sep 2017

CAR-T is Nearly Here: How Will It Be Delivered?

As we anticipate the first-ever CAR-T therapy market approval we look at the important aspect of treatment delivery and viral vector strategies. Cell and gene therapy is increasingly coming into…

September 7, 2017 - 4 minutesmins - By External Contributor

News and Trends 20 Oct 2022

VectorBuilder raises funds for gene delivery R&D

VectorBuilder Biotechnology (Guangzhou) Co., Ltd., a gene delivery enterprise, has completed a series C round with CNY410 million ($56.7 million). The funding was co-led by Legend Capital. The proceeds will…

October 20, 2022 - 2 minutesmins - By Jim Cornall

VectorBuilder Research and Manufacturing Campus

News and Trends 2 Nov 2022

VectorBuilder to build gene delivery campus after $57M funding

Gene delivery technology company VectorBuilder Inc. has announced the completion of $57 million in funding. The funding, co-led by Legend Capital, will support the construction of VectorBuilder’s new Gene Delivery…

November 2, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 2 May 2017

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

…biogenesis of viral RNA by interacting with a viral protein called Rev and preventing any replication,” explains Steens. The activity is specific only to HIV viruses and therefore doesn’t affect…

May 2, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Sep 2022

Synairgen to collaborate on study of patients hospitalized due to respiratory viruses

Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral infection and recovery in hospital patients. The UNIVERSAL (Understanding Infection, Viral Exacerbation and Respiratory Symptoms…

September 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 23 Feb 2018

Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany

…the viral polymerase enzyme, letermovir targets its terminase to block viral replication, which is unique to the virus. CEO of AiCuris, Holger Zimmerman, describes this as “game-changing” as the drug…

February 23, 2018 - 3 minutesmins - By Alex Dale

News and Trends 20 Feb 2017

CEVEC is Transforming Vaccine Development starting with Zika

…viral vaccines and gene therapy vectors. Their CAP technology consists of robust cell-lines which are extensively documented and able to be easily scaled up for cost-efficient production processes. With their…

February 20, 2017 - 6 minutesmins - By External Contributor

News and Trends 29 Jul 2016

Gene Therapy for severe Hemophilia has new Phase I/II Results

…expression and an AAV5 viral vector) which are the only ones to have clinically proven multi-year durability and demonstrated safety. Now, uniQure has announced additional results from AMT-060 Phase I/II…

July 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

In Depth 11 Jun 2025

Can gene therapy treat vision loss?

…In the case of Luxturna, a copy of the RPE65 gene is delivered to the patient’s eye using a viral vector. The virus is modified to eliminate its capacity for…

June 11, 2025 - 12 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B

Topical Gene Therapy Shows Early Promise for Inherited Skin Disease

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

CAR-T is Nearly Here: How Will It Be Delivered?

VectorBuilder raises funds for gene delivery R&D

VectorBuilder to build gene delivery campus after $57M funding

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

Synairgen to collaborate on study of patients hospitalized due to respiratory viruses

Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany

CEVEC is Transforming Vaccine Development starting with Zika

Gene Therapy for severe Hemophilia has new Phase I/II Results

Can gene therapy treat vision loss?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!